Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram Understanding Cagrilintide: Unlocking Its Potential with GLP 1 Medications Nevermore Lane Incretin polyagonists as an alternative to bariatric surgery to manage obesity Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as Cagrilintide, an amylin analog, enhances the weight loss effects of semaglutide or tirzepatide by slowing gastric emptying, suppressing glucagon, and reducing appetite. It works synergistically with